Infusional ECarboF in patients with advanced breast cancer: A very active and well-tolerated out-patient regimen

Annals of Oncology

Volumn 11, Issue 12, 2000, Pages 1557-1561

  Hugli A ^a   Sappino, A P ^a   Anchisi, S ^b   Mermillod, B ^a   Schafer, P ^a   Anguenot, J L ^a   Bonnefoi, H ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Hopital de Sion   (Switzerland)

Author keywords

Breast cancer; Carboplatinum; Chemotherapy; Continuous 5 fluorouracil

Indexed keywords

CARBOPLATIN; CISPLATIN; EPIRUBICIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; AREA UNDER THE CURVE; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CHEMOTHERAPY INDUCED EMESIS; CONTINUOUS INFUSION; DRUG EFFICACY; DRUG HALF LIFE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; THROMBOSIS;

EID: 0034488593     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008378220547     Document Type: Article

References (21)

1. Treatment of breast cancer
2. 5-Fluorouracil by protracted venous infusion: A review of recent clinical studies
3. Low-dose continuous intravenous infusion of 5-fluorouracil for metastatic breast cancer patients
4. Biochemical basis for cisplatinum and 5-fluorouracil synergism in human tumors
5. Phase II study of continuous infusion fluorouracil with epirubicin and cisplatin in patients with metastatic and locally advanced breast cancer: An active new regimen
6. High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer
7. Phase II study of continuous infusional 5-fluorouracil with epirubicin and carboplatin (instead of cisplatin) in patients with metastatic/locally advanced breast cancer (infusional ECarboF): A very active and well-tolerated outpatient regimen
8. Randomized phase II trial of infusional fluorouracil, epirubicin, and cyclophosphamide versus infusional fluorouracil, epirubicin, and cisplatin in patients with advanced breast cancer
9. Carcinoma of the breast: Criteria of inoperability
10. Carboplatin dosage: Prospective evaluation of a simple formula based on renal function
11. Very low dose of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial
12. A prospective analysis of 949 long-term central venous access catheters for ambulatory chemotherapy in patients with gastrointestinal malignancy
13. Complications of venous access ports in 132 patients with disseminated testicular cancer treated with polychemotherapy
14. Complications of an implantable venous access device (Port-a-cath®) during intermittent continuous infusion of chemotherapy
15. Optimal dosing of paclitaxel and doxorubicin in metastatic breast cancer
16. Paclitaxel by three-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: High antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study
17. Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer
18. Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancer
19. Epirubicin, cisplatin and oral UFT with leucovorin (ECU): A phase I-II study in patients with advanced upper gastrointestinal tract cancer